Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdelali Bouidioua"'
Autor:
Jérôme Solassol, Pierre Brousset, Etienne Coyaud, Sylvain Godreuil, Abdelali Bouidioua, Benoit Roch, Jean-Louis Pujol, Xavier Quantin, Isabelle Rouquette, Romain Senal, Julien Mazieres, Julie A. Vendrell
Purpose:The detection of preexisting EGFRT790M subclones and the assessment of their clinical significance in the pretreatment of patients with EGFRT790M non–small cell lung cancer (NSCLC) remain unclear.Experimental Design:A total of 179 tumor sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ae5bfb4ae0374672fb199f0fdd465e
https://doi.org/10.1158/1078-0432.c.6527717
https://doi.org/10.1158/1078-0432.c.6527717
Autor:
Julie A. Vendrell, Jérôme Solassol, Isabelle Rouquette, Pierre Brousset, Etienne Coyaud, Romain Senal, Abdelali Bouidioua, Benoit Roch, Xavier Quantin, Sylvain Godreuil, Julien Mazieres, Jean-Louis Pujol
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (14), pp.4280-4289. ⟨10.1158/1078-0432.CCR-18-2683⟩
Clinical Cancer Research, American Association for Cancer Research, 2019, 25 (14), pp.4280-4289. ⟨10.1158/1078-0432.CCR-18-2683⟩
Purpose: The detection of preexisting EGFRT790M subclones and the assessment of their clinical significance in the pretreatment of patients with EGFRT790M non–small cell lung cancer (NSCLC) remain unclear. Experimental Design: A total of 179 tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca07306ab4218aa8d964f8ccdec1b6b
https://hal.umontpellier.fr/hal-02448987
https://hal.umontpellier.fr/hal-02448987
Autor:
Julie A, Vendrell, Julien, Mazieres, Romain, Senal, Isabelle, Rouquette, Xavier, Quantin, Jean-Louis, Pujol, Benoit, Roch, Abdelali, Bouidioua, Sylvain, Godreuil, Etienne, Coyaud, Pierre, Brousset, Jérôme, Solassol
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(14)
The detection of preexistingA total of 179 tumor samples from patients treated or not with a first-generation tyrosine kinase inhibitor (TKI) was analyzed. The presence of ultra-low levels of preexisting EGFRWith a ddPCR linear performance of 0.999 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4bbca6e1579ff0832ad3b9d999d0f70
https://pubmed.ncbi.nlm.nih.gov/30936123
https://pubmed.ncbi.nlm.nih.gov/30936123
